Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Q4 net profit rebounds to $2.1 billion
Yahoo/AP
Wed, 01/23/13 - 10:34 am
Tags:
earnings, Novartis
Novartis Scores EU Approval for Meningitis Vaccine
Motley Fool
Tue, 01/22/13 - 11:22 am
Tags:
Europe, Novartis, vaccines, meningitis, Bexsero
Novartis gets EMA nod for Jetrea
FiercePharma
Sat, 01/19/13 - 12:14 pm
Tags:
Novartis, EMA, Jetrea, regulatory
Novartis Earnings: Patent Cliff Edition
The Motley Fool
Sat, 01/19/13 - 12:06 pm
Tags:
Novartis, patent, earnings
The Future Of Zalicus In 2013
Seeking Alpha
Wed, 01/16/13 - 08:01 am
Tags:
Zalicus, Novartis, Questcor, CelSci, Celsion, Antares
Novartis Earnings: How Will They Grow?
Motley Fool
Mon, 01/14/13 - 10:35 am
Tags:
earnings, Novartis
Novartis says Afinitor reduces tumors in rare genetic disease
Reuters
Fri, 01/11/13 - 11:57 am
Tags:
Afinitor, Novartis, TSC
Novartis to Focus on Mid-Sized Deals, CEO Jimenez Says
Bloomberg
Tue, 01/8/13 - 09:05 am
Tags:
Novartis, Joe Jimenez, M&A
Creative Destruction And The Pharmaceutical Industry
Seeking Alpha
Mon, 01/7/13 - 10:26 am
Tags:
Genomic Health, Eli Lilly, Novartis, Pfizer, Teva
India set to rule in Novartis patent case
FiercePharma
Sat, 01/5/13 - 11:12 am
Tags:
patent, Novartis, legal, India
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
Tags:
MS, multiple sclerosis, Teva, Copaxone, Rebif, Pfizer, Merck KGaA, Biogen Idec, Avonex, Bayer, Betaseron, Novartis, Extavia, Sanofi, Tysabri, Aubagio, Elan, Gilenya, BG-12
Novartis’s Lucentis Wins U.K. Backing as Drug’s Price Cut
Bloomberg
Thu, 01/3/13 - 11:35 am
Tags:
UK, Novartis, Lucentis, diabetic macular edema
Novartis CEO: Industry needs more R&D, less sales and marketing, WSJ reports
Yahoo/Fly on the Wall
Wed, 01/2/13 - 11:48 am
Tags:
Novartis, Pharma CEOs, R&D, Joe Jimenez
2 Drug Companies That Belong In Your Portfolio
Seeking Alpha
Wed, 01/2/13 - 11:45 am
Tags:
AstraZeneca, Novartis
2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool
Mon, 12/31/12 - 04:36 pm
Tags:
multiple sclerosis, drugs, Teva Pharmaceuticals, Pfizer, Merck, Biogen, Bayer, Novartis
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Tags:
Arqule, Array Biopharma, Celldex, Aveo Pharmaceutical, Curis, Exelixis, MorphoSys, Genmab, Novartis, Incyte, Seattle Genetics, YM BioSciences
Novartis orphan drug Signifor gets another approval
Fierce Pharma
Mon, 12/17/12 - 01:31 pm
Tags:
Signifor, Novartis, Cushing's syndrome, FDA
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Mon, 12/17/12 - 09:31 am
Tags:
FDA, drug approvals, Ariad Pharmaceuticals, Novartis, Dendreon, Medivation, Bayer, ONYX Pharmaceuticals, Otsuka, Bristol-Myers Squibb
Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
Seeking Alpha
Mon, 12/10/12 - 12:30 pm
Tags:
Aveo Pharmaceutical, tivozanib, Pfizer, ONYX Pharmaceuticals, Novartis, GSK, Eli Lilly, Exelixis
5 Drug Hopefuls That Are Going to Change Your Life: Part 3
Motley Fool
Sun, 12/9/12 - 11:29 am
Tags:
Actonel, Reclast, Boniva, Warner Chilcott, Amgen, Prolia, Odanacatib, Merck, Novartis, GSK, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.